Reading this on a mobile device? Try our optimized mobile version here:

January 7, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  • Conservative transfusion strategy best for upper GI bleeds
    Patients with upper gastrointestinal bleeding have better survival under a restrictive transfusion approach rather than a more liberal strategy, according to a Spanish study. Researchers said transfusions are necessary for patients at risk of death from severe GI bleeding, but most cases are not at that level. Dr. Loren Laine of Yale University wrote in an accompanying piece that the study provided "important evidence to guide clinical practice." MedPage Today (free registration) (1/2) LinkedInFacebookTwitterEmail this Story
Quotient is on a roll with new FDA approvals & GPO contracts
More good news from Quotient! Not only do we have FDA-approved Reagent Red Blood Cells products, but also just approved Rare Antisera, including Anti-s and Anti-Wra. We also have new 3-yr agreements with Premier Inc. and the General Services Administration. Great products and value from the one manufacturer focused on manual testing. Contact us today.

  Science & Health 
  • Flu activity on the rise, CDC reports
    The CDC issued an update noting an early and serious flu season, with the number of people seeking care for influenza-like conditions increasing from 2.8% to 5.6% in a four-week period. "Antiviral treatment, started as early as possible after becoming ill, is recommended for any patients with confirmed or suspected influenza who are hospitalized, seriously ill, or ill and at high risk of serious influenza-related complications, including young children, people 65 and older, people with certain underlying medical conditions, and pregnant women," the agency said. News (1/4) LinkedInFacebookTwitterEmail this Story
  Hot Topics 

Top five news stories selected by AABB SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends 
  Industry News & Practice 
  • Lifecodes to become part of Immucor
    Hologic has entered a deal to sell its subsidiary Lifecodes to Immucor for at least $85 million. Lifecodes is a provider of molecular and antibody-based assays for businesses specializing in transplant diagnostics, specialty coagulation and transfusion medicine. The deal is expected to be finalized in the second fiscal quarter. (free registration) (1/4) LinkedInFacebookTwitterEmail this Story
  • Evotec buys custom cells and reagents supplier
    Cell Culture Service, a supplier of custom cells and cell-based reagents, has been acquired by Evotec for $1.5 million upfront plus as much as $1.4 million in milestone fees. Evotec said the deal would improve its ability to offer integrated drug discovery and early development services for drugmakers. "CCS' experience and technologies for large-scale cell production are a perfect fit with Evotec's screening and in vitro pharmacology activities," Evotec COO Mario Polywka said. Genetic Engineering & Biotechnology News (1/3) LinkedInFacebookTwitterEmail this Story
  • Intrexon helps Sanford-Burnham create iPSC collection
    Intrexon granted the Sanford-Burnham Medical Research Institute access to its Laser-Enabled Analysis and Processing instrument and RheoSwitch Therapeutic System. The technologies will help the research institute build its collection of human induced pluripotent stem cells. In return, Intrexon may get commercial and patent rights to technology developments arising from the collaboration. Genetic Engineering & Biotechnology News (1/3) LinkedInFacebookTwitterEmail this Story
  • Health care employment up by 45K last month
    U.S. Bureau of Labor Statistics data show the health care sector generated 45,000 jobs in December. Hospitals added 12,000 jobs, nursing and residential care facilities added 10,000 and ambulatory services added 23,000. The industry added 338,000 jobs for the year. Healthcare Finance News (1/4) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • CMS postpones HIPAA operating rules deadline
    Enforcement of HIPAA operating rules has been moved to April, according to a CMS Office of E-Health Standards and Services statement. "Industry feedback suggests that HIPAA-covered entities have not reached a threshold whereby a majority of covered entities would be able to be in compliance with operating rules by Jan. 1, 2013," according to the agency. (1/4) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Upcoming audioconference to address unrelated hematopoietic cell donors
    A Wednesday AABB audioconference titled "Medical Considerations in the Evaluation of Unrelated Hematopoietic Cell Donors" will examine how the medical suitability of hematopoietic cell donors is evaluated to ensure their safety and to provide the safest and most effective HCs for patients undergoing transplantation. Registration materials are available online. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Director of Quality SystemsRock River Valley Blood CenterUS - IL - Rockford
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
Click here to view more job listings.

If money be not thy servant, it will be thy master. The covetous man cannot so properly be said to possess wealth, as that may be said to possess him."
--Francis Bacon,
British author and statesman

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information